HUTCHMED Highlights Publication of Phase III SACHI Results in The Lancet
— First randomized Phase III trial confirming the efficacy of MET inhibition…
SOS Limited Announces Development of Tier III Modular Data Center at Longfellow Ranch, Texas
NEW YORK, Dec. 22, 2025 /PRNewswire/ -- SOS Limited (NYSE: SOS) ("SOS"…
InnoCare Announces Achievement of Primary Endpoint in Phase IIb Study of Orelabrutinib for SLE and Approval of Phase III Clinical Trial
BEIJING, Dec. 14, 2025 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE:…
Tejas Networks emerges as a leading supplier of IP Routing products across the country for BharatNet Phase III packages
BENGALURU, India, Dec. 11, 2025 /PRNewswire/ -- Tejas Networks (BSE: 540595) (NSE:…
Ashika Investment Managers launches Ashika Mid & Small Cap Fund, an open-ended Category III AIF
MUMBAI, India, Dec. 9, 2025 /PRNewswire/ -- Ashika Investment Managers Pvt. Ltd.…
Carl H. Sharperson III Joins MATTER Board of Directors
December 03, 2025 10:00 ET | Source: MATTER MINNEAPOLIS, MN , Dec.…
Sustainable Markets Initiative Hosts Landmark Private Capital Mobilization Convening in London, with a report back session attended by His Majesty King Charles III
LONDON, Dec. 2, 2025 /PRNewswire/ -- Yesterday, the Sustainable Markets Initiative hosted…
Quetzal Therapeutics Launches Phase III Clinical Trial of Oral QTX-2101 for Acute Promyelocytic Leukemia (APL)
CHICAGO, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Quetzal Therapeutics, a biopharmaceutical company…
Roche presents new phase III pivotal data for vamikibart in uveitic macular edema (UME), a serious cause of vision loss
Vamikibart is the first non-steroid targeted therapy designed to address inflammation driving…
Roche and Alnylam advance zilebesiran into global phase III cardiovascular outcomes trial for people with uncontrolled hypertension
Phase III trial informed by comprehensive KARDIA data set generated through three…
